GPT and metabolic disease: Indeed, a recent cross-sectional study on 98 adult patients affected by metabolic disorders reported a positive association between GDF15 circulating levels and serum markers of liver injury (AST, ALT, and GGT) and inflammation (i.e., acute-phase proteins) [9].